Equity (Tables)

6 Months Ended

Mar. 31, 2020

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

	For the three months				For the six months
Stock-based Compensation Expense - by award type	ended March 31,				ended March 31,
(in thousands)	2020		2019		2020		2019
Employee stock options	$	4	$	7	$	9	$	14
Restricted stock units and awards		552		396		928		782
Performance stock units and awards		363		229		655		169
Employee stock purchase plan		46		42		93		82
Outside director equity awards and fees in common stock		80		47		161		99
Total stock-based compensation expense	$	1,045	$	721	$	1,846	$	1,146

Schedule of Stock-based Compensation Expense - By Expense Type

	For the three months				For the six months
Stock-based Compensation Expense - by expense type	ended March 31,				ended March 31,
(in thousands)	2020		2019		2020		2019
Cost of revenue	$	202	$	109	$	338	$	220
Selling, general, and administrative		591		473		1,076		632
Research and development		252		139		432		294
Total stock-based compensation expense	$	1,045	$	721	$	1,846	$	1,146

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per share:

	For the three months				For the six months
Basic and Diluted Net Loss Per Share	ended March 31,				ended March 31,
(in thousands, except per share)	2020		2019		2020		2019
Numerator:
Loss from continuing operations	$	(5,081)	$	(4,994)	$	(6,416)	$	(10,532)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share		(5,081)		(4,994)		(6,416)		(10,532)
Denominator:
Denominator for basic and fully diluted net loss per share - weighted average shares outstanding		29,033		27,652		28,931		27,592
Net loss per basic and fully diluted share	$	(0.18)	$	(0.18)	$	(0.22)	$	(0.38)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation		2,161		849		1,704		535

Schedule of Common Stock Reserved for Future Issuances

As of March 31, 2020, we had common stock reserved for the following future issuances:

	Number of Common
	Stock Shares Available for
Future Issuances	Future Issuances
Exercise of outstanding stock options	46,342
Unvested restricted stock units and awards	1,799,427
Unvested performance stock units and awards (at 200% maximum payout)	1,812,000
Purchases under the employee stock purchase plan	428,349
Issuance of stock-based awards under the Equity Plans	822,155
Purchases under the officer and director share purchase plan	88,741
Total reserved	4,997,014